BRAUNOVIDON
100MG/G UNG 20G I
Announcement of launch, break or close-out of marketing of a medicinal product
| Type of announcement | Effective date | Alternate medicines ? | Reason for interruption/cessation of marketing | Estimated renewal date |
|---|---|---|---|---|
| Interruption of marketing | 17.05.2022 |
0203323, 0249431, 0062320 |
Manufacturing reasons | Přibližně do konce června 2022 |
| Resumption of marketing | 22.12.2021 | |||
| Interruption of marketing | 11.10.2021 |
0203323, 0249431, 0062320 |
Manufacturing reasons | začátek ledna 2022 |
| Interruption of marketing | 11.10.2021 |
0203323, 0249431, 0062320 |
Manufacturing reasons | začátkem prosince 2021 |
| Resumption of marketing | 27.04.2021 | |||
| Interruption of marketing | 15.03.2021 |
0203323, 0249431, 0062320 |
Commercial/marketing reasons | 30.4.2021 |
| Resumption of marketing | 17.03.2020 | |||
| Interruption of marketing | 20.02.2020 |
0062320 |
Manufacturing reasons | 31.03.2020 |
| Interruption of marketing | 28.01.2020 |
0062320 |
Manufacturing reasons | 20.02.2020 |
| Interruption of marketing | 08.01.2020 |
0016320, 0016321, 0203323, 0062320 |
Manufacturing reasons | 28.01.2020 |
| Resumption of marketing | 29.11.2019 | |||
| Interruption of marketing | 12.11.2019 |
0203323, 0062320 |
Manufacturing reasons | 16.12.2019 |
| Interruption of marketing | 07.10.2019 |
0203323, 0062320 |
Manufacturing reasons | 12.11.2019 |
| Placing on the market | 01.05.2008 |
All reports are available in the Overview.
cz